Avectas

SME

Avectas

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem. Sign in

Avectas

Address

Kildare, Ireland

Contact

https://avectas.com/contact-us/

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem.

Matchmaking

Connect with Avectas

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

Avectas last news

26/01/2024

GenEdit Tackles "Delivery, Delivery, Delivery" with Up-to-$644M Genentech Collaboration

The collaboration, which was announced on Tuesday, aims to develop non-viral, non-lipid, hydrophilic nanoparticles (HNPs) discovered through GenEdit's NanoGalaxy ¬ģ platform. NanoGalaxy includes a library consisting of thousands of unique non-viral, non-lipid, hydrophilic polymer nanoparticles. Using this combinatorial library of polymers, NanoGalaxy creates nanoparticles consisting of hydrophilic polymer backbones with diverse small-molecule side chains, all combined with a variety of structures to yield hundreds of thousands of structurally distinct polymers capable of targeting certain cells. The post GenEdit Tackles "Delivery, Delivery, Delivery" with Up-to-$644M Genentech Collaboration appeared first on GEN - Genetic Engineering and Biotechnology News .

15/01/2024

Double nationaliteŐĀ de Karim Wade : Serigne Mboup en phase avec TAS

[...] Karim Wade Le président de l'Union des chambres de commerce du Sénégal, par ailleurs candidat déclaré à l'élection présidentielle de  2024, soutient le président Thierno Alassane Sall dans son recours de contestation  qui sera déposé demain mardi  devant l [...]

01/02/2023

Avectas announces the appointment of Dr. Ann Brady as Chief Business Officer

Leading the commercialization of the Solupore¬ģ Platform for Next-Generation Gene-Modified Cell Therapies with Superior Cell Health and Functionality DUBLIN, Ireland and Cambridge MA, USA, 1st February 2023: Avectas, a cell engineering technology business, announces the appointment of Dr.Ann Brady as Chief Business Officer (CBO) following the successful launch its Solupore¬ģ Platform for the manufacture of‚Ķ The post Avectas announces the appointment of Dr. Ann Brady as Chief Business Officer appeared first on Avectas .